These guys are the leading small pet health distribution company...

These guys are the leading small pet health distribution company in the US which should help penetration and hence benefit MLA. Sorry for the length but just copied Medivet press release.

FOR IMMEDIATE RELEASE
MEDIVET-AMERICA PARTNERS WITH BUTLER SCHEIN ANIMAL HEALTH
TO DISTRIBUTE WORLDS LEADING STEM CELL TECHNOLOGY TO U.S. VETERINARIANS
LAS VEGAS, NV ¯ MediVet-America, the global leader in veterinary stem cell technology and regenerative medicine,
has entered into a distribution partnership with Butler Schein Animal Health, a division of Henry Schein, the leading
companion animal health distribution company in the U.S., to sell and distribute stem cell kits and equipment to
veterinarians serving the nation’s fast-growing $50 billion pet industry.
The announcement was made today at the Western Veterinary Conference in Las Vegas, Nevada, by Jeremy Delk,
CEO of MediVet-America.
The two companies will partner to sell and distribute MediVet-America’s breakthrough stem cell technology to more
than 26,000 veterinary clinics nationwide. The Adipose-Derived Stem Cell Procedure Kit and state of the art equipment
co-developed with Medical Australia enable veterinarians to remove a small sample of fat, separate stem cells from the
fat, then activate and inject them into the affected areas.
“We are pleased to be teaming up with Butler Schein, the largest companion animal health distribution company in the
nation,” said Jeremy Delk, CEO of MediVet-America. “Their strong track record in sales and distribution will further fuel
our rapid growth and bring this breakthrough technology to more leading veterinary practices across the country.”
To introduce the distribution partnership, Delk said MediVet has developed an exclusive program of product and
service offers that will be made available only to Butler Schein customers.
Adult animal stem cell technology uses the body’s own regenerative healing power to help treat dogs, cats, horses and
other animals suffering from painful arthritis, hip dysplasia and tendon, ligament and cartilage injuries and other
ailments.
-morePage
Two
MediVet-America, Butler Schein partnership
Veterinary practitioners in more than 200 markets throughout 42 states now perform the drug-free procedure entirely in
their own clinics more quickly, effectively and economically than earlier generation animal stem cell therapy. MediVet-
America’s new treatment, developed in Australia, is available in 26 countries worldwide.
Dr. Mike Hutchinson, worlds leading animal stem cell practitioner was quoted “this announcement is a breakthrough
and is going to allow even more of our colleagues unparalleled access to Medivet’s superior technology providing the
most affordable and efficacious stem cell therapy in the industry”. Dr. Hutchinson, just returned from Tokyo speaking
on this technology, has spoken around the world about Stem Cell Therapy. Dr. Hutchinson has as done over 300
procedures over the last 18 months in his practice outside of Pittsburgh.
Partnering with the leading animal health manufacturers in the world, Butler Schein maintains an order-fill ratio greater
than 98 percent, and is positioned to bring the broadest selection of veterinary products and strategic business
solutions to veterinarians, including:
• A comprehensive product offering for companion animal, equine and large animal practices including
biologicals, diagnostics, nutritionals, parasiticides and pharmaceuticals
• Technology hardware and software solutions
• Capital equipment, supply products and repair services
• Practice design and remodeling, client marketing and financial solutions
Stem cells are basic biological cells with the ability to differentiate into specialized tissue cells and regenerate new cells
to replace or repair damaged tissue. The stem cells used in veterinary medicine are not embryonic, which have
attracted controversy over the years, but are taken from adipose (fat) tissue of the adult animal.
Americans spent an estimated $50.8 billion in 2011 on their companion animals, according to the American Pet
Products Association, up from $28.5 billion in 2001. The cost of MediVet-America’s stem cell treatment is about $1,800
for small animals, $2,400 for horses. Stem cells also can be frozen and banked through MediVet Lab Services for
future use.
MEDIVET-AMERICA
A research and development company and global leader in veterinary stem cell technology, MediVet-America provides
innovative cell applications for the therapeutic care of animals. Headquartered in Nicholasville, Kentucky, MediVet-America
develops advanced cellular designed kits and services for the treatment of osteoarthritis and degenerative joint disease. The
company also offers MediVet Lab Services in multiple locations around the world that provides technical support for inhouse
stem cell vets, as well as regional and national Adipose stem cell processing and cryo banking services for pets at a
young age or for a maintenance program, autologous conditioned serum processing, and cell counting for in-house stem cell
procedures. www.MediVet-America.com
BUTLER SCHEIN ANIMAL HEALTH
Butler Schein Animal Health is the leading U.S. companion animal health distribution company. Headquartered in Dublin,
Ohio, the company operates through 18 distribution centers and 12 telecenters. Approximately 900 Butler Schein Animal
Health team members, including 300 field sales representatives and 200 telesales and customer support representatives,
serve animal health customers in all 50 states. www.ButlerShein.com